Episode
How Voice Biomarkers Can Detect Disease Before Symptoms
- Published
- Jun 9, 2026
- Duration seconds
- 436
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-digital-health-podcast-with-fexingo-wearables-diagnostics-and-health-software-7872006/episodes/how-voice-biomarkers-can-detect-disease-before-symptoms/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-digital-health-podcast-with-fexingo-wearables-diagnostics-and-health-software-7872006/how-voice-biomarkers-can-detect-disease-before-symptoms.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Lucas and Luna explore the emerging field of vocal biomarker technology, where companies like Sonde Health and Vocalis Health analyze subtle changes in voice patterns to screen for conditions ranging from depression to COVID-19 and even Parkinson's disease. They break down how a 20-second voice sample can reveal physiological cues invisible to the naked eye, the regulatory pathway these devices are navigating, and why the concept raises important privacy questions. The hosts discuss a specific pilot program where a health insurer used voice analysis to flag early signs of respiratory infection, and what it would take for this tech to become a routine part of primary care. No hype—just the signal. #VoiceBiomarkers #DigitalHealth #SondeHealth #VocalisHealth #Wearables #HealthTech #BusinessPodcast #FexingoBusiness #ArtificialIntelligence #RemotePatientMonitoring #PreventiveMedicine #SpeechAnalysis #ParkinsonsDetection #COVIDScreening #MentalHealthTech #HealthDataPrivacy #RegulatoryPathway #PodcastEpisode Keep every episode free: buymeacoffee.com/fexingo